Racial and Ethnic Differences in Initiation and Discontinuation of Antidementia Drugs by Medicare Beneficiaries
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Objectives: To examine racial and ethnic differences in initiation and time to discontinuation of antidementia medication in Medicare beneficiaries. Design: Retrospective cohort study. Setting: Secondary analysis of 2009–10 enrollment, claims, and Part D prescription data for a 10% national sample of U.S. Medicare fee‐for‐service beneficiaries. Participants: Beneficiaries aged 65 and older with Alzheimer's disease or related dementia ( ADRD ) before 2009 and no fills for antidementia medications in the first half of 2009 (N = 84,043). Measurements: Initiation was defined as having one or more fills for antidementia medication in the second half of 2009 and discontinuation as a gap in coverage of 30 days or more during the year after initiation. The Andersen Behavioral Model was used to guide covariate selection. Results: Overall, 3,481 (4.1%) of previous nonusers initiated antidementia medication in the second half of 2009. Of those initiating one drug class (acetylcholinesterase inhibitors ( AC h EI s) or memantine), 9% later added the other class, and 2% switched classes. Of initiators, 23% discontinued within 1 month, and 62% discontinued within 1 year. Hispanic beneficiaries were more likely than white beneficiaries to initiate (adjusted odds ratio = 1.25, 95% confidence interval ( CI ) = 1.10–1.41). Black and white beneficiaries did not differ in likelihood of initiation. Hispanic (adjusted hazard ratio ( aHR ) = 1.56, 95% CI = 1.34–1.82) and black ( aHR = 1.25, 95% CI = 1.08–1.44) beneficiaries discontinued at a faster rate than white beneficiaries. Conclusion: Initiation of antidementia medications was no different in black and white beneficiaries and more likely in Hispanic beneficiaries; black and Hispanic beneficiaries discontinued at a faster rate. More research into reasons explaining these differences is needed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tariot, P. N., Farlow, M. R., Grossberg, G. T., Graham, S. M., McDonald, S., Gergel, I., & for the Memantine Study Group (2004) · JAMA · doi:10.1001/jama.291.3.317 · Cited by 1,403
Practice Guideline for the Treatment of Patients With Obsessive-Compulsive Disorder
(2008) · APA Practice Guidelines for the Treatment of Psychiatric Disorders: Comprehensive Guidelines and Guideline Watches · doi:10.1176/appi.books.9780890423363.149114 · Cited by 1,028
Donepezil and memantine for moderate-to-severe Alzheimer's disease
Howard, R., McShane, R., Lindesay, J., Ritchie, C., Baldwin, A., Barber, R., Burns, A., Dening, T., Findlay, D., Holmes, C., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1106668 · Cited by 782
Kaduszkiewicz, H., Zimmermann, T., Beck-Bornholdt, H.-P., & van den Bussche, H. (2005) · BMJ · doi:10.1136/bmj.331.7512.321 · Cited by 522
The Accuracy of Medicare Claims as an Epidemiological Tool: The Case of Dementia Revisited
Taylor, Jr., Østbye, T., Langa, K. M., Weir, D., & Plassman, B. L. (2009) · Journal of Alzheimer's Disease · doi:10.3233/jad-2009-1099 · Cited by 354
Rountree, S. D., Chan, W., Pavlik, V. N., Darby, E. J., Siddiqui, S., & Doody, R. S. (2009) · Alzheimers Res Ther · doi:10.1186/alzrt7 · Cited by 181
Racial and Ethnic Disparities in the Treatment of Dementia Among Medicare Beneficiaries
Zuckerman, I. H., Ryder, P. T., Simoni-Wastila, L., Shaffer, T., Sato, M., Zhao, L., & Stuart, B. (2008) · The Journals of Gerontology Series B: Psychological Sciences and Social Sciences · doi:10.1093/geronb/63.5.s328 · Cited by 102
Cited by
Babulal, G. M., Quiroz, Y. T., Albensi, B. C., Arenaza‐Urquijo, E., Astell, A. J., Babiloni, C., Bahar‐Fuchs, A., Bell, J., Bowman, G. L., Brickman, A. M., et al. (2019) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2018.09.009 · Cited by 528
“[150] Thorpe CT, Fowler NR, Harrigan K, Zhao X, Kang Y, Hanlon JT,”
BackgroundImpact of dementia: Health disparities, population trends, care interventions, and economic costs
Aranda, M. P., Kremer, I. N., Hinton, L., Zissimopoulos, J., Whitmer, R. A., Hummel, C. H., Trejo, L., & Fabius, C. (2021) · Journal of the American Geriatrics Society · doi:10.1111/jgs.17345 · Cited by 390
Aducanumab: Appropriate Use Recommendations
Cummings, J., Aisen, P., Apostolova, L. G., Atri, A., Salloway, S., & Weiner, M. (2021) · The Journal of Prevention of Alzheimer's Disease · doi:10.14283/jpad.2021.41 · Cited by 316
“Dementia medication discontinuation rates have been shown to be higher in African American and Hispanic patients than White patients; racially and ethnically appropriate strategies may be required to optimize adherence (65).”
Watson, J., Giebel, C., Green, M., Darlington‐Pollock, F., & Akpan, A. (2021) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.5419 · Cited by 39
Dong, X., Tsang, C. C. S., Wan, J. Y., Chisholm-Burns, M. A., Finch, C. K., Tsao, J. W., Browning, J. A., Garuccio, J., Zeng, R., & Wang, J. (2024) · Exploratory Research in Clinical and Social Pharmacy · doi:10.1016/j.rcsop.2024.100420 · Cited by 1
“22 We bridge the gap in MTM and ADRD research by examining the effects of the Medicare MTM program on racial/ethnic disparities in adherence to antidementia medications among older beneficiaries with ADRD.”
Background
Metadata
- Authors
- Thorpe, C. T., Fowler, N. R., Harrigan, K., Zhao, X., Kang, Y., Hanlon, J. T., Gellad, W. F., Schleiden, L. J., & Thorpe, J. M.
- Venue
- Journal of the American Geriatrics Society
- Publisher
- Wiley
- Published
- 2016-08-22
- Volume
- 64
- Issue
- 9
- Pages
- 1806-1814
- ISSN
- 0002-8614 (ISSN-L)
- 1532-5415
- OpenAlex
- W2515332210
- Cited by
- 46
- References
- 7
- FWCI
- 1.81
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.